Spironolactone VS dutasteride for female pattern hair loss
    Treatment 9/7/2024

    At a glance
    In this question or advice post, the primary subjects mentioned are
    ๐Ÿ’Š Spironolactone (oral)
    ๐Ÿ’Š Dutasteride (oral)
    ๐Ÿ’Š Minoxidil (oral)
    ๐Ÿ’ง Minoxidil (topical)
    the tone is ๐Ÿ˜ neutral.

    Other terms

    Spironolactone is more potent and lowers testosterone and DHT, while dutasteride only impacts DHT. For female hair loss, checking hormones and considering treatments like oral minoxidil, spironolactone, or topical minoxidil is recommended.
    View this post in the Community โ†’

    Similar Community Posts Join

    5 / 575 results

    Related Research

    6 / 1000+ results
      Antiandrogens and Androgen Inhibitors in Dermatologic Treatments

      research Antiandrogens and Androgen Inhibitors

      November 2020 in “Elsevier eBooks”
      Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.
      Interventions for Female Pattern Hair Loss

      research Interventions for female pattern hair loss

      21 citations , May 2016 in “The Cochrane library”
      Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.
      Female Pattern Hair Loss

      research Female Pattern Hair Loss

      16 citations , June 2008 in “Springer eBooks”
      Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.
      Androgens in Women: Hormone-Modulating Therapies for Androgen-Mediated Cutaneous Disorders

      research Androgens in women

      34 citations , October 2018 in “Journal of The American Academy of Dermatology”
      Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.